| scholarly article | Q13442814 |
| P50 | author | Brian K Coombes | Q37377462 |
| P2093 | author name string | J B Mahony | |
| P2860 | cites work | Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease | Q37891247 |
| Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
| Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae | Q37892713 | ||
| Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases | Q37898698 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| Cytokine and adhesion molecule expression in human monocytes and endothelial cells stimulated with bacterial heat shock proteins. | Q39833287 | ||
| MTT assay overestimates human airway smooth muscle cell number in culture. | Q50751471 | ||
| Pathogenesis of atherosclerosis | Q62046795 | ||
| The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life | Q67674363 | ||
| Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells | Q73167392 | ||
| Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells | Q73201827 | ||
| Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein | Q74531668 | ||
| Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response | Q24322374 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Infection with Chlamydia trachomatis alters the tyrosine phosphorylation and/or localization of several host cell proteins including cortactin. | Q30452836 | ||
| Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells | Q34077029 | ||
| Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis | Q34207431 | ||
| Chlamydia pneumoniae (TWAR). | Q35367697 | ||
| Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
| Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry | Q35532691 | ||
| In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae | Q36524413 | ||
| A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide | Q37879971 | ||
| Chlamydia pneumoniae and vascular disease | Q37880177 | ||
| Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 | ||
| Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells | Q37881299 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen | Q37882581 | ||
| Murine models of Chlamydia pneumoniae infection and atherosclerosis | Q37883205 | ||
| Rabbit model for Chlamydia pneumoniae infection | Q37883934 | ||
| Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group | Q37883953 | ||
| Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae | Q37884222 | ||
| Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line | Q37884265 | ||
| Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. | Q37886690 | ||
| Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. | Q37889936 | ||
| Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q37890128 | ||
| Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain | Q37890285 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chlamydia pneumoniae infection | Q11299062 |
| endothelium | Q111140 | ||
| Chlamydia pneumoniae | Q62869737 | ||
| P304 | page(s) | 2909-2915 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). | |
| P478 | volume | 67 |
| Q44210302 | Assessment of periodontal conditions and systemic disease in older subjects. II. Focus on cardiovascular diseases |
| Q34397021 | Assessment of subclinical atherosclerosis and cardiovascular risk. |
| Q24791856 | Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review |
| Q37868568 | Atherogenic effects of chlamydia pneumoniae: refuting the innocent bystander hypothesis |
| Q35127516 | Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature |
| Q22241306 | Atherosclerosis and infection: is the jury still not in? |
| Q36028330 | Atherosclerosis: humoral and cellular factors of inflammation |
| Q37191384 | Campylobacter jejuni cocultured with epithelial cells reduces surface capsular polysaccharide expression. |
| Q51726841 | Chlamydia pneumoniae and Cardiovascular Disease. |
| Q37866728 | Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis |
| Q33927267 | Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo |
| Q37856309 | Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation |
| Q37861412 | Chlamydia trachomatis infection induces cleavage of the mitotic cyclin B1 |
| Q37853901 | Chlamydophila pneumoniae infection leads to smooth muscle cell proliferation and thickening in the coronary artery without contributions from a host immune response |
| Q43254870 | Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by gamma interferon |
| Q33186908 | Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. |
| Q35169118 | Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis |
| Q33987842 | Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. |
| Q37875477 | Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity |
| Q37876556 | Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae |
| Q38237730 | Programming of the lung by early-life infection. |
| Q37873971 | The adventitia of atherosclerotic coronary arteries frequently contains Chlamydia pneumoniae |
| Q35130850 | The involvement of AMPK/GSK3-beta signals in the control of metastasis and proliferation in hepato-carcinoma cells treated with anthocyanins extracted from Korea wild berry Meoru |
| Q37876418 | The role of chlamydia pneumoniae in atherosclerosis - recent evidence from animal models: response |
| Q35662826 | Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota |
| Q37874954 | cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection |
Search more.